Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Walgreens Boots Alliance, Inc.
  6. Summary
    WBA   US9314271084

WALGREENS BOOTS ALLIANCE, INC.

(WBA)
  Report
Delayed Nasdaq  -  04:00 2022-07-01 pm EDT
38.56 USD   +1.74%
07/01Truist Securities Adjusts Walgreens Boots Alliance's Price Target to $42 from $50, Keeps Hold Rating
MT
07/01UBS Adjusts Walgreens Boots Alliance Price Target to $40 From $42, Maintains Neutral Rating
MT
07/01FACTBOX : Dealmaking hits the rocks due to stormy markets
RE
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
06/27/2022 06/28/2022 06/29/2022 06/30/2022 07/01/2022 Date
42.19(c) 40.96(c) 40.87(c) 37.9(c) 38.56(c) Last
7 140 577 7 825 456 6 099 225 15 611 717 9 291 855 Volume
+1.30% -2.92% -0.22% -7.27% +1.74% Change
More quotes
Estimated financial data (e) (USD)
Sales 2022 132 B - -
Net income 2022 5 329 M - -
Net Debt 2022 9 035 M - -
P/E ratio 2022 6,28x
Yield 2022 4,99%
Sales 2023 135 B - -
Net income 2023 3 390 M - -
Net Debt 2023 7 348 M - -
P/E ratio 2023 9,97x
Yield 2023 5,10%
Capitalization 33 326 M 33 326 M -
EV / Sales 2022 0,32x
EV / Sales 2023 0,30x
Nbr of Employees 315 000
Free-Float 60,9%
More Financials
Company
Walgreens Boots Alliance, Inc. specializes in the distribution of pharmaceutical products. Net sales break down by activity as follows: - retail distribution (83.1%): selling prescription drugs, OTC medicines, beauty and cosmetic products, etc. in the United States (90.1% of net sales) and International (9.9%). At the end of August 2020, the activity is ensured through 13,449 outlets (including 9,021 in the United... 
Read more
Sector
Drug Retailers
Calendar
06/30 | 07:00amEarnings Release
More about the company
Ratings of Walgreens Boots Alliance, Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B-
More Ratings
All news about WALGREENS BOOTS ALLIANCE, INC.
07/01Truist Securities Adjusts Walgreens Boots Alliance's Price Target to $42 from $50, Keep..
MT
07/01UBS Adjusts Walgreens Boots Alliance Price Target to $40 From $42, Maintains Neutral Ra..
MT
07/01FACTBOX : Dealmaking hits the rocks due to stormy markets
RE
07/01Deutsche Bank Adjusts Walgreens Boots Alliance Price Target to $44 From $46, Maintains ..
MT
07/01Credit Suisse Lowers Walgreens Boots Alliance's PT to $43 from $52, Notes Limited Visib..
MT
07/01Kohl's ends sale talks with Franchise Group, shares plunge
RE
06/30US Stocks Fall After Consumer Spending Misses Views
MT
06/30Walgreens, Duck Creek fall; Spirit Airlines, Lindsay rise
AQ
06/30US Stocks Drop Thursday on Slower-Than-Expected Consumer Spending, Recession Jitters
MT
06/30S&P 500 closes the book on its steepest first-half slide since 1970
RE
06/30MANAGEMENT'S DISCUSSION AND ANALYSIS Item 2. Management's discussion and analysis of fi..
AQ
06/30S&P 500 closes the book on its biggest first-half plunge since 1970
RE
06/30US STOCKS-S&P 500 wobbles to the end of its worst first-half since 1970
RE
06/30Walgreens Boots Alliance Fiscal Q3 Adjusted EPS, Sales Decline -- Shares Sink Thursday
MT
06/30Equities Drop Midday After Consumption Expenditures Rise Slower Than Expected
MT
More news
News in other languages on WALGREENS BOOTS ALLIANCE, INC.
07/01FACTBOX : Les transactions sont en baisse en raison de la tempête sur les marchés
06/30Les actions américaines chutent après que les dépenses des consommateurs aient manqué l..
06/30Wall Street conclut dans le rouge son pire semestre depuis 1970
06/30Les actions américaines chutent jeudi en raison d'un ralentissement plus important que ..
06/30MÄRKTE USA/Wall Street mit anhaltenden Zinssorgen schwach
More news
Analyst Recommendations on WALGREENS BOOTS ALLIANCE, INC.
More recommendations
Analysis
Walgreens profit plunges on opioid settlement, lower pharmacy sales
Chart WALGREENS BOOTS ALLIANCE, INC.
Duration : Period :
Walgreens Boots Alliance, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends WALGREENS BOOTS ALLIANCE, INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 19
Last Close Price 38,56 $
Average target price 44,56 $
Spread / Average Target 15,6%
EPS Revisions
Managers and Directors
Rosalind Gates Brewer Chief Executive Officer & Director
James Kehoe Global Chief Financial Officer & Executive VP
Stefano Pessina Executive Chairman
Francesco Tinto Global Chief Information Officer & Senior VP
Kevin M. Ban Chief Medical Officer
Sector and Competitors
1st jan.Capi. (M$)
WALGREENS BOOTS ALLIANCE, INC.-26.07%33 326
MCKESSON CORPORATION32.57%47 314
CARDINAL HEALTH, INC.1.51%14 466
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD-9.46%8 976
SINOPHARM GROUP CO. LTD.12.15%7 564
MATSUKIYOCOCOKARA & CO.28.87%5 707